EMA Positive Opinion Received for ECOVAXXIN® MS

AI SummaryClose X

ECO Animal Health Group plc has received a Positive Opinion from the European Medicines Agency's Committee for Medicinal Products for Veterinary Use for its poultry vaccine, ECOVAXXIN® MS, against Mycoplasma synoviae infections, which can cause significant economic losses in laying hens. This milestone paves the way for an EU marketing authorisation in the first quarter of 2026 and a commercial launch in the second half of 2026, with the company also planning additional geographic submissions and further R&D pipeline product submissions within the next twelve months.

Disclaimer*

UK 100

Latest directors dealings